Sunday, Oct 25, 2026
Focus on the big picture

Biogen CEO to step down after Alzheimer's drug snags

Reuters, 04 May 2022
Biogen CEO Michel Vounatsos to step down as the drugmaker announces plans to pull back on selling the Alzheimer's drug Aduhelm.


#Biogen #MichelVounatsos #AlzheimerDrug #News #Reuters

Subscribe: http://smarturl.it/reuterssubscribe

Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.

Get the latest news on: http://reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en
Related Articles